Dear Members of our Working Group,
Humanity is experiencing a disastrous pandemic by the new SARS-CoV-2 coronavirus (disease Covid-19). This disease has direct implications on human life conditions but also foreseeable consequences in our society. Management can rely only on research to early understand the tropism of the disease and to quickly develop ways of management. Four study sites of the Hellenic Sepsis Study Group start a dynamic clinical trial on personalized host-directed treatment for patients with the acute hyper-inflammatory complication of Covid-19. This is done through the ESCAPE prospective clinical trial (Efficiency in management of organ dysfunction associated with infection by the novel SARS-CoV-2 virus through a personalized immunotherapy approach). We invite more study sites of our group to join this trial in the attempt to achieve better treatment outcomes. This historic period we need to understand that research is the ONLY solution to retrieve quick answers and to reverse the ominous consequences.
The Board of the Hellenic Institute for the Study of Sepsis